Teva Pharmaceutical Industries Ltd (TEVA)-Financial and Strategic SWOT Analysis Review

Teva Pharmaceutical Industries Ltd (TEVA)-Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH33504FSA
  • |
  • Pages: 79
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Teva Pharmaceutical Industries Ltd (TEVA)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Teva Pharmaceutical Industries Ltd (Teva) carries out the research, development, manufacture and commercialization of generic and specialty medicines. It provides specialty medicines in central nervous system (CNS), respiratory, cancer, women's health and other therapy areas. The company offers generic medicines in a range of dosage forms, including capsules, tablets, injectables, liquids, inhalants, creams and ointments. Teva also provides over-the-counter (OTC) products, as well as active pharmaceutical ingredients (APIs), the essential raw materials to the drug manufacturing industry. It carries out OTC business principally through PGT Healthcare, a consumer healthcare joint venture with The Procter & Gamble Company (P&G). The company conducts its worldwide operations through a network of global subsidiaries. Teva is headquartered in Petach Tikva, Israel.

Teva Pharmaceutical Industries Ltd Key Recent Developments

Feb 13, 2017: Teva Reports Full Year and Fourth Quarter 2016 Financial Results

Feb 06, 2017: Teva Appoints Dr. Yitzhak Peterburg as Interim Chief Executive Officer, Succeeding Erez Vigodman

Jan 06, 2017: Teva Provides 2017 Financial Outlook

Dec 22, 2016: Teva Reaches Settlement with Government on FCPA

Dec 22, 2016: Teva Pharmaceutical Paying $519 Million to Settle FCPA Charges

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Section 1-About the Company 6

Teva Pharmaceutical Industries Ltd-Key Facts 6

Teva Pharmaceutical Industries Ltd-Key Employees 7

Teva Pharmaceutical Industries Ltd-Key Employee Biographies 8

Teva Pharmaceutical Industries Ltd-Major Products and Services 9

Teva Pharmaceutical Industries Ltd-Pharmaceutical Pipeline Products Data 11

Teva Pharmaceutical Industries Ltd, Pipeline Products by Therapy Area 11

Teva Pharmaceutical Industries Ltd, Pipeline Products by Development Phase 12

Teva Pharmaceutical Industries Ltd-History 13

Teva Pharmaceutical Industries Ltd-Company Statement 28

Teva Pharmaceutical Industries Ltd-Locations And Subsidiaries 29

Head Office 29

Other Locations & Subsidiaries 29

Joint Venture 37

Section 2-Company Analysis 38

Teva Pharmaceutical Industries Ltd-Business Description 38

Teva Pharmaceutical Industries Ltd-Corporate Strategy 39

Teva Pharmaceutical Industries Ltd-SWOT Analysis 40

SWOT Analysis-Overview 40

Teva Pharmaceutical Industries Ltd-Strengths 40

Teva Pharmaceutical Industries Ltd-Weaknesses 41

Teva Pharmaceutical Industries Ltd-Opportunities 42

Teva Pharmaceutical Industries Ltd-Threats 44

Teva Pharmaceutical Industries Ltd-Key Competitors 45

Section 3-Company Financial Ratios 46

Financial Ratios-Capital Market Ratios 46

Financial Ratios-Annual Ratios 47

Performance Chart 49

Financial Performance 49

Financial Ratios-Interim Ratios 50

Financial Ratios-Ratio Charts 51

Section 4-Company's Lifesciences Financial Deals and Alliances 52

Teva Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 52

Teva Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 53

Teva Pharmaceutical Industries Ltd, Recent Deals Summary 54

Section 5-Company's Recent Developments 55

Feb 13, 2017: Teva Reports Full Year and Fourth Quarter 2016 Financial Results 55

Feb 06, 2017: Teva Appoints Dr. Yitzhak Peterburg as Interim Chief Executive Officer, Succeeding Erez Vigodman 62

Jan 06, 2017: Teva Provides 2017 Financial Outlook 64

Dec 22, 2016: Teva Reaches Settlement with Government on FCPA 66

Dec 22, 2016: Teva Pharmaceutical Paying $519 Million to Settle FCPA Charges 67

Dec 05, 2016: Teva Appoints Dipankar Bhattacharjee as President and Chief Executive Officer, Global Generic Medicines Group, Succeeding Siggi Olafsson 68

Nov 15, 2016: Teva Reports Third Quarter 2016 Results 69

Nov 08, 2016: Teva Announces Appointment of New Chief Legal Officer 71

Oct 26, 2016: Teva Pharmaceuticals and IBM Expand Global Partnership to Enable Drug Development and Chronic Disease Management with Watson 72

Aug 25, 2016: Teva Plunges After Two U.S. Copaxone Patents Invalidated 74

Section 6-Appendix 75

Methodology 75

Ratio Definitions 75

About GlobalData 79

Contact Us 79

Disclaimer 79

List of Figures

Teva Pharmaceutical Industries Ltd, Pipeline Products by Therapy Area 11

Teva Pharmaceutical Industries Ltd, Pipeline Products by Development Phase 12

Teva Pharmaceutical Industries Ltd, Performance Chart (2012-2016) 49

Teva Pharmaceutical Industries Ltd, Ratio Charts 51

Teva Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 52

Teva Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 53

List of Tables

Teva Pharmaceutical Industries Ltd, Key Facts 6

Teva Pharmaceutical Industries Ltd, Key Employees 7

Teva Pharmaceutical Industries Ltd, Key Employee Biographies 8

Teva Pharmaceutical Industries Ltd, Major Products and Services 9

Teva Pharmaceutical Industries Ltd, Number of Pipeline Products by Therapy Area 11

Teva Pharmaceutical Industries Ltd, Number of Pipeline Products by Development Stage 12

Teva Pharmaceutical Industries Ltd, History 13

Teva Pharmaceutical Industries Ltd, Subsidiaries 29

Teva Pharmaceutical Industries Ltd, Joint Venture 37

Teva Pharmaceutical Industries Ltd, Key Competitors 45

Teva Pharmaceutical Industries Ltd, Ratios based on current share price 46

Teva Pharmaceutical Industries Ltd, Annual Ratios 47

Teva Pharmaceutical Industries Ltd (Cont...1), Annual Ratios 48

Teva Pharmaceutical Industries Ltd, Interim Ratios 50

Teva Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 52

Teva Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 53

Teva Pharmaceutical Industries Ltd, Recent Deals Summary 54

Currency Codes 75

Capital Market Ratios 75

Equity Ratios 76

Profitability Ratios 76

Cost Ratios 77

Liquidity Ratios 77

Leverage Ratios 77

Efficiency Ratios 78

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Tesaro Inc, Sandoz Inc, Pfizer Inc, Mylan Laboratories Ltd, Merck & Co Inc, MediciNova Inc, Mapi Pharma Ltd, Mallinckrodt Plc, Hayat Pharmaceutical Industries, GlaxoSmithKline Plc, D-Pharm Ltd, Chiesi Farmaceutici SpA, Bristol-Myers Squibb Company, BiondVax Pharmaceuticals Ltd, AstraZeneca Plc, Apotex Inc, Amgen Inc, Allergan Plc

Teva Pharmaceutical Industries Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license

Single User License
USD 125 INR 8431
Site License
USD 250 INR 16863
Corporate User License
USD 375 INR 25294

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com